Patient Guide: Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 97 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06579105
Status: ACTIVE_NOT_RECRUITING
Condition: Diabetes Mellitus, Diabetes Mellitus, Type 2
Phase: PHASE2

Where You Can Participate

This study is available at 97 locations across the country.

Top locations include:
  • • Mobile, Alabama
  • • Sheffield, Alabama
  • • Vestavia Hills, Alabama
  • • And 94 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. - Join Clinical Trial NCTNCT06579105

How to Join This Clinical Trial - NCTNCT06579105

Learn how to participate in this PHASE2 trial studying an investigational therapy for Diabetes Mellitus, Diabetes Mellitus, Type 2. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Diabetes Mellitus, Diabetes Mellitus, Type 2. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Diabetes Mellitus, Diabetes Mellitus, Type 2
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06579105 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 97 locations. Find a study site near you:

Clinical Research Site

Mobile, Alabama 36608 - United States

Status: Contact for availability

Clinical Research Site

Sheffield, Alabama 35660 - United States

Status: Contact for availability

Clinical Research Site

Vestavia Hills, Alabama 35216 - United States

Status: Contact for availability

Clinical Research Site

Tucson, Arizona 85710 - United States

Status: Contact for availability

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: Contact for availability

Clinical Research Site

Long Beach, California 90815 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90017 - United States

Status: Contact for availability

Clinical Research Site

Newport Beach, California 92660 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95821 - United States

Status: Contact for availability

Clinical Research Site

Waterbury, Connecticut 06708 - United States

Status: Contact for availability

And 87 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Diabetes Mellitus, Diabetes Mellitus, Type 2:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships